Fosamax Femur Fractures and Osteonecrosis of the Jaw to be Reviewed by FDA in September

Fosamax Femur Fractures and Osteonecrosis of the Jaw to be Reviewed by FDA in September Ennis & Ennis, P.A. advises all individuals harmed by bisphosphonates that an FDA advisory committee (http://www.fda.gov/AdvisoryCommittees/Calendar/ucm262477.htm) will hold a meeting on September 9, 2011 at 8 AM to discuss the benefits and risks of long term bisphosphonate use for the treatment and prevention of osteoporosis. The drugs that will be reviewed will be Fosamax, Actonel, Boniva and Reclast. (PRWEB) July 18, 2011 On July 14, 2011 the FDA announced an FDA advisory committee will hold a m
Contributor
PR Web
PR Web
Lanham, Maryland
Law Marketing
1.800.345.5572
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Download

Related Documents in PR Web
MCLE Sales

Categories